Emerging candidates, such as tumor-infiltrating lymphocytes (TILs), relative eosinophil count (REC), lactate dehydrogenase (LDH), and S100 calcium-binding protein B (S100B), offer additional prognostic or predictive value but require further validation. This evidence concerns the gene S100B and neoplasm.